STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Stock options, exercised	187,500
Incentive stock options, granted	100,000
Stock-based compensation expense	$ 224,070	$ 142,599
Deferred compensation expense	$ 1,715,053
Incentive Stock | Director of Sales for Apeiron
Defined Benefit Plan Disclosure [Line Items]
Incentive stock options, granted	100,000
Chief Executive Officer
Defined Benefit Plan Disclosure [Line Items]
Stock options, exercised	187,500
Shares issued as a result of options exercised	187,500
Stock price	$ 0.22